Ablation Technologies

Ablation Technologies

Global Ablation Technologies Market to Reach US$9.1 Billion by 2030

The global market for Ablation Technologies estimated at US$4.7 Billion in the year 2023, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Laser / Light Ablation segment is estimated at 9.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 12.7% CAGR

The Ablation Technologies market in the U.S. is estimated at US$1.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$768.5 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Ablation Technologies Market - Key Trends & Drivers Summarized

Ablation technologies encompass a range of minimally invasive procedures used to destroy abnormal tissue, such as tumors or heart arrhythmias, through various energy sources. These technologies include radiofrequency ablation (RFA), laser ablation, microwave ablation, cryoablation, and high-intensity focused ultrasound (HIFU). Ablation procedures are increasingly preferred over traditional surgical methods due to their precision, reduced recovery times, and lower risk of complications. They are commonly used in oncology for the treatment of liver, lung, kidney, and prostate cancers, as well as in cardiology for treating atrial fibrillation and other cardiac arrhythmias.

The adoption of ablation technologies has been significantly influenced by advancements in imaging and guidance systems, which enhance the accuracy and effectiveness of ablation procedures. Real-time imaging technologies, such as MRI and CT scans, allow for precise targeting of the treatment area, minimizing damage to surrounding healthy tissue. The growing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, is driving the demand for effective and minimally invasive treatment options. Additionally, ongoing research and development are expanding the applications of ablation technologies to new therapeutic areas, including neurology and orthopedics, further broadening their clinical utility.

The growth in the ablation technologies market is driven by several factors. Firstly, the increasing prevalence of cancer and cardiovascular diseases is boosting demand for effective minimally invasive treatments. Secondly, advancements in imaging and guidance technologies are enhancing the precision and outcomes of ablation procedures. Thirdly, the continuous innovation in ablation devices, including the development of novel energy sources and delivery systems, is expanding the range of treatable conditions. Lastly, the growing preference for outpatient and ambulatory procedures, driven by the benefits of reduced recovery times and healthcare costs, is promoting the adoption of ablation technologies. These factors collectively contribute to the robust growth of the ablation technologies market.

Select Competitors (Total 79 Featured) -

• Abbott Laboratories, Inc.
• Boston Scientific Corporation
• Biotronik SE & Co. KG
• AngioDynamics, Inc.
• Arthrex, Inc.
• AtriCure, Inc.
• Apyx Medical Corporation
• CardioFocus, Inc.
• Acoustic Medsystems, Inc.
• Alpinion Medical Systems Co., Ltd.
• CathVision ApS
• Ablatus Therapeutics
• Acutus Medical, Inc.
• Blueacre Technologoy
• Adagio Medical

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.